Incidence and Risk Factors of Low Anterior Resection Syndrome

Zagazig University120 enrolled

Overview

Sphincter sparing surgery is oftentimes associated with bowel dysfunction complaints, namely the low anterior resection syndrome (LARS). The LARS questionnaire is widely used to assess this syndrome. With advances in colorectal surgery, sparing sphincter surgeries are gaining popularity. But symptoms after surgery can affect the quality of life which has psychomotor effects. Low anterior resection syndrome score is a worldwide known questionnaire. Many countries have accredited validation and translation of this questionnaire, but to our knowledge; it is the first time in Egypt.

Study Type

OBSERVATIONAL

Enrollment

120

Conditions

Colorectal Cancer

Interventions

LARS score questionnaireOTHER

LARS score questionnaire is filled by the patient after anterior resection for rectal cancer to study the quality of life

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age more than 18 * Diagnosed patients with rectal adenocarcinoma and who received low anterior resection with anastomosis creation or after a minimum 6 months interval after stoma reversal. * Tumors of the rectum (2-15 cm) from anal verge Exclusion Criteria: * • cognitive dysfunction * Having a history of inflammatory bowel disease or any disease with bowel function impairment namely, Crohn's disease, irritable bowel syndrome, ulcerative colitis or others. * Age less than 18 * Metastatic cancer or tumor recurrence * Rectal tumors within 2 cm from anal verge( abdominoperineal)

Locations (1)

Zagazig University Hospitals

Zagazig, Egypt

Outcomes

Primary Outcomes

age

age of the patients in years was recorded from patient records

Time frame: from 2017 to 2022

sex

sex of patients was recorded from patient records

Time frame: from 2017 to 2022

medical disease

medical disease like diabetes and hypertension was recorded from patient records

Time frame: from 2017 to 2022

site of tumor

tumor site was determined in Cm from anal verge by colonoscopy

Time frame: from 2017 to 2022

neoadjuvant therapy

history of neoadjuvant therapy before surgery was obtained from patients records

Time frame: from 2017 to 2022

site of anastmosis

site of anastmosis after resection was recorded as colo-rectal or colo-anal

Time frame: from 2017 to 2022

type of meso-rectal excision

excision of meso-rectum was recorded if it was partial or complete

Time frame: from 2017 to 2022

adjuvant therapy

it was recorded from patients records if he\\she had chemo- or radiotherapy post-operatively

Time frame: from 2017 to 2022

type of surgery

from records; surgery was open or laparoscopic

Time frame: from 2017 to 2022

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.